Cargando…

Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers

SIMPLE SUMMARY: The high heterogeneity of hepatocellular carcinoma (HCC), and the lack of druggable mutations, hamper the identification of unequivocal molecular classifiers and limit the discovery of selective therapeutic treatments. Moreover, the lack of circulating biomarkers guiding the choice o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gramantieri, Laura, Giovannini, Catia, Suzzi, Fabrizia, Leoni, Ilaria, Fornari, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472624/ https://www.ncbi.nlm.nih.gov/pubmed/34572776 http://dx.doi.org/10.3390/cancers13184550

Ejemplares similares

Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs
por: Giovannini, Catia, et al.
Publicado: (2021)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
por: Fornari, Francesca, et al.
Publicado: (2021)

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
por: Gramantieri, Laura, et al.
Publicado: (2022)

Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives
por: Giovannini, Catia, et al.
Publicado: (2016)

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2021)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
por: Fornari, Francesca, et al.
Publicado: (2022)

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
por: Gramantieri, Laura, et al.
Publicado: (2022)

MicroRNAs in Animal Models of HCC
por: Fornari, Francesca, et al.
Publicado: (2019)

Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2020)

Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2014)

LncRNAs as novel players in hepatocellular carcinoma recurrence
por: Gramantieri, Laura, et al.
Publicado: (2018)

MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
por: Bergamini, Christian, et al.
Publicado: (2023)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2016)

The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2018)

Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2016)

Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017)

Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017)

Animal Models of Hepatocellular Carcinoma Prevention
por: Shankaraiah, Ram C., et al.
Publicado: (2019)

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
por: Mandraffino, Giuseppe, et al.
Publicado: (2022)

Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes
por: Zelli, Veronica, et al.
Publicado: (2020)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
por: Castellani, Giorgia, et al.
Publicado: (2023)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)

Cell Wall Surface Properties of Kluyveromyces marxianus Strains From Dairy-Products
por: Perpetuini, Giorgia, et al.
Publicado: (2019)

The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020)

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
por: Fornari, Francesca, et al.
Publicado: (2015)

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
por: Bonilha, Isabella, et al.
Publicado: (2021)

Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2013)

Hepatic circulation: Potential for therapeutic intervention
por: Ballet, François
Publicado: (1990)

Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets
por: Kankeu Fonkoua, Lionel, et al.
Publicado: (2018)

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2015)

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019)

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2016)

Molecular and Circulating Biomarkers of Brain Tumors
por: Jelski, Wojciech, et al.
Publicado: (2021)

Molecular and Circulating Biomarkers of Gastric Cancer
por: Jelski, Wojciech, et al.
Publicado: (2022)

Molecular and Circulating Biomarkers in Patients with Glioblastoma
por: Senhaji, Nadia, et al.
Publicado: (2022)

Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
por: Nazio, Francesca, et al.
Publicado: (2019)

Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
por: Kumar, Dhiraj, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_93na7rdc2dl3qkjf2f2ejcale9